A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

NCT02313077 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: MVA-BN-filo
BIOLOGICAL: Ad26. ZEBOV
OTHER: Placebo

Sponsor

Crucell Holland BV